INDV financial statements
The full income statement, balance sheet, and cash-flow statement for Indivior Pharmaceuticals Inc. (INDV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.24B+4.3% | 1.19B+8.7% | 1.09B+21.3% | 901M+13.9% | 791M | |
| 994M+3.9% | 957M+4.1% | 919M+22.7% | 749M+12.8% | 664M | ||
| Cost of revenue | 246M+6.5% | 231M+24.2% | 186M+17.0% | 159M+25.2% | 127M | |
| — | 919M-14.3% | 1.07B+29.6% | 827M | — | ||
| Research & development | 97.0M-9.3% | 107M+0.9% | 106M+47.2% | 72.0M+38.5% | 52.0M | |
| Selling, general & administrative | 634M+3.6% | 612M+8.3% | 565M+21.2% | 466M | — | |
| Operating income | 262M+589.5% | 38.0M+125.0% | -152M-97.4% | -77.0M-136.2% | 213M | |
| Interest expense | 45.0M+9.8% | 41.0M+7.9% | 38.0M+31.0% | 29.0M+7.4% | 27.0M | |
| Interest & investment income | 22.0M-4.3% | 23.0M-46.5% | 43.0M+126.3% | 19.0M | — | |
| Gain (loss) on equity securities | 0.00+100.0% | -9.00M | 0.00 | 0.00 | — | |
| Pre-tax income | 239M+1095.0% | 20.0M+113.8% | -145M-68.6% | -86.0M-145.3% | 190M | |
| Income tax | 29.0M+123.1% | 13.0M+168.4% | -19.0M+55.8% | -43.0M-186.7% | -15.0M | |
| Net income | 210M+2900.0% | 7.00M+105.6% | -126M-200.0% | -42.0M-120.5% | 205M | |
| $1.64+3180.0% | $0.05+105.4% | -$0.92-206.7% | -$0.30 | — | ||
| EPS (basic) | $1.68+3260.0% | $0.05+105.4% | -$0.92-206.7% | -$0.30 | — | |
| Weighted-avg shares (basic) | 125M-5.3% | 132M-3.6% | 137M-1.4% | 139M-4.6% | 146M | |
| Weighted-avg shares (diluted) | 128M-3.8% | 133M-2.9% | 137M-1.4% | 139M-8.5% | 152M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 652M-21.2% | 827M-34.2% | 1.26B-0.2% | 1.26B-12.8% | 1.44B | ||
| Cash & equivalents | 195M-38.9% | 319M+0.9% | 316M-59.2% | 774M-29.8% | 1.10B | |
| Short-term investments | 0.00-100.0% | 1.00M-98.9% | 94.0M | — | — | |
| Accounts receivable | 253M-0.4% | 254M+0.0% | 254M | — | — | |
| Inventory | 153M-8.4% | 167M+32.5% | 126M+10.5% | 114M+20.0% | 95.0M | |
| Prepaid expenses | 34.0M-35.8% | 53.0M+1.9% | 52.0M | — | — | |
| Other current assets | 16.0M-23.8% | 21.0M | — | — | — | |
| 1.20B-8.7% | 1.32B-25.1% | 1.76B-0.6% | 1.77B-3.4% | 1.83B | ||
| Property, plant & equipment | 144M+44.0% | 100M+19.0% | 84.0M+55.6% | 54.0M-6.9% | 58.0M | |
| Operating lease right-of-use | 26.0M-33.3% | 39.0M-2.5% | 40.0M | — | — | |
| Goodwill | 2.00M+0.0% | 2.00M-60.0% | 5.00M | — | — | |
| Long-term investments | 28.0M+3.7% | 27.0M-34.1% | 41.0M | — | — | |
| Deferred tax assets | 323M+16.6% | 277M-3.1% | 286M | — | — | |
| Other non-current assets | 27.0M-30.8% | 39.0M+8.3% | 36.0M | — | — | |
| Total non-current assets | — | — | 691M+35.5% | 510M+31.4% | 388M | |
| 914M-1.1% | 924M-27.9% | 1.28B+25.7% | 1.02B+26.7% | 804M | ||
| Accounts payable | 48.0M-23.8% | 63.0M+61.5% | 39.0M | — | — | |
| Accrued liabilities | 250M+15.7% | 216M+10.8% | 195M | — | — | |
| Short-term & current debt | 29.0M+61.1% | 18.0M+500.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M | |
| Current lease liability | 10.0M+0.0% | 10.0M+11.1% | 9.00M | — | — | |
| Other current liabilities | 0.00-100.0% | 11.0M-72.5% | 40.0M | — | — | |
| 1.30B-21.3% | 1.65B-14.9% | 1.94B+13.0% | 1.72B+5.5% | 1.63B | ||
| Long-term debt | 290M-7.9% | 315M+32.9% | 237M+0.0% | 237M-0.8% | 239M | |
| Non-current lease liability | 22.0M-31.3% | 32.0M-5.9% | 34.0M | — | — | |
| Operating lease liability (total) | 32.0M-23.8% | 42.0M | — | — | — | |
| Other non-current liabilities | 21.0M+16.7% | 18.0M-41.9% | 31.0M | — | — | |
| -98.0M+70.9% | -337M-83.2% | -184M-1126.7% | -15.0M-112.4% | 121M | ||
| Common stock | 62.0M+0.0% | 62.0M-8.8% | 68.0M | — | — | |
| Additional paid-in capital | 112M+24.4% | 90.0M+2.3% | 88.0M | — | — | |
| Retained earnings | -243M+45.1% | -443M-53.8% | -288M | — | — | |
| Accumulated other comprehensive income | -30.0M+16.7% | -36.0M-20.0% | -30.0M | — | — | |
| Total equity incl. non-controlling | — | — | 0.00-100.0% | 51.0M-74.9% | 203M | |
| Total liabilities & equity | 1.20B-8.7% | 1.32B-25.1% | 1.76B | — | — | |
| Common shares issued | 125M+0.0% | 125M-8.8% | 137M+0.7% | 136M-80.6% | 702M | |
| Shares outstanding (cover) | 125M+0.3% | 125M-8.7% | 137M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -27.0M-175.0% | 36.0M+112.0% | -300M-7400.0% | -4.00M-101.1% | 353M | ||
| Depreciation & amortization | 10.0M-37.5% | 16.0M+6.7% | 15.0M-6.3% | 16.0M+33.3% | 12.0M | |
| Intangible amortization | — | — | 10.0M+100.0% | 5.00M-16.7% | 6.00M | |
| Share-based compensation | 26.0M+8.3% | 24.0M+14.3% | 21.0M+31.3% | 16.0M | — | |
| Deferred income taxes | -46.0M-757.1% | 7.00M+110.9% | -64.0M+38.5% | -104M | — | |
| Change in receivables | -3.00M-400.0% | 1.00M-97.0% | 33.0M+57.1% | 21.0M | — | |
| Change in inventory | -18.0M-141.9% | 43.0M+616.7% | 6.00M-80.0% | 30.0M | — | |
| -66.0M-195.7% | 69.0M+172.6% | -95.0M+57.2% | -222M | — | ||
| Capital expenditure | 66.0M+127.6% | 29.0M+262.5% | 8.00M+60.0% | 5.00M+25.0% | 4.00M | |
| Free cash flow | -93.0M-1428.6% | 7.00M+102.3% | -308M-3322.2% | -9.00M-102.6% | 349M | |
| Acquisitions | 0.00 | 0.00-100.0% | 129M | 0.00 | 0.00 | |
| Other investing activities | 0.00 | 0.00+100.0% | -3.00M-200.0% | -1.00M | — | |
| -30.0M+70.6% | -102M-59.4% | -64.0M+36.6% | -101M | — | ||
| Long-term debt issued | 0.00-100.0% | 332M | 0.00 | 0.00-100.0% | 250M | |
| Long-term debt repaid | 17.0M-92.9% | 240M+1900.0% | 12.0M+300.0% | 3.00M-98.7% | 236M | |
| Common stock issued | 2.00M-33.3% | 3.00M+0.0% | 3.00M+50.0% | 2.00M+100.0% | 1.00M | |
| Common stock repurchased | 11.0M-93.6% | 173M+424.2% | 33.0M-63.3% | 90.0M | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | — | -2.00M | 0.00 | 0.00 | — | |
| FX effect on cash | — | 0.00-100.0% | 1.00M+200.0% | -1.00M | — | |
| Interest paid | 34.0M+21.4% | 28.0M+7.7% | 26.0M+44.4% | 18.0M | — | |
| Income taxes paid | 38.0M-17.4% | 46.0M+43.8% | 32.0M-43.9% | 57.0M | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 4.49B+189.6% | 1.55B-27.0% | 2.12B-35.8% | 3.30B+530.4% | 524M | |
| P/E | 21.4×-90.3% | 221.4× | — | 16.1×+530.4% | 2.6× | |
| P/S | 3.6×+177.7% | 1.3×-44.6% | 2.4×-43.6% | 4.2×+530.4% | 0.7× | |
| P/B | — | — | — | 27.3×+530.4% | 4.3× | |
| P/FCF | — | 221.4× | — | 9.5×+530.4% | 1.5× | |
| Earnings yield | 4.7%+935.9% | 0.45% | — | 6.2%-84.1% | 39.1% | |
| FCF yield | — | 0.45% | — | 10.6%-84.1% | 66.6% | |
| Source filing | 10-K | 10-K | 20-F | 10-K | 10-K |
About this data
Source: INDV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all INDV filings on SEC EDGAR → Not investment advice.
